TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis

10Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In addition to regulating the activation of nuclear factor (NF)-κB and c-Jun N-terminal kinase (JNK), TGF-β activated kinase 1 (TAK1) also upregulates the activation of AMP-activated protein kinase (AMPK) and autophagy. In the liver, TAK1-mediated autophagy plays a role in preventing excessive lipid accumulation induced by starvation and fat overload. TAK1-mediated autophagy and inhibition of mechanistic target of rapamycin complex 1 (mTORC1) prevent liver fibrosis and tumor development.

Author supplied keywords

Cite

CITATION STYLE

APA

Seki, E. (2014). TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis. Molecular and Cellular Oncology, 1(4). https://doi.org/10.4161/23723548.2014.968507

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free